市場調査レポート

商品コード

心血管治療薬の世界市場 2025-2029

Global Cardiovascular Therapeutics Market 2025-2029

出版日: 2025年03月22日
発行: TechNavio
ページ情報: 英文 219 Pages
納期: 即納可能

カスタマイズ可能

価格

PDF (Single User License)

USD 2,500 358,925円

レポートPDFをご購入者の1名のみがご利用頂けるライセンスです。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は何回でも可能ですが、印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 4,000 574,280円

レポートPDFを同一組織内のすべての方にて共有ご使用頂けるライセンスです。ご利用人数に制限はありません。PDF内のテキスト等のコピー＆ペースト可能です。PDFの印刷は制限なく何回でも可能ではありますが、印刷物のご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=143.57円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

心血管治療薬市場は2024-2029年に253億2,000万米ドル、予測期間中のCAGRは4.6%で成長すると予測されます。

当レポートでは、心血管治療薬市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、心血管疾患の危険因子の増加、高度な診断法の利用可能性、高コレステロール血症の有病率の上昇によって牽引されています。

市場範囲
基準年	2025
終了年	2029
予測期間	2025-2029
成長モメンタム	加速
前年比2025年	4.3%
CAGR	4.6%
増分額	253億2,000万米ドル

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要企業の分析に加え、包括的な市場規模データ、地域分析によるセグメント、ベンダー情勢が含まれています。レポートには過去データと予測データがあります。

本調査では、新規経口抗凝固薬（NOACs）の登場が、今後数年間の心血管治療薬市場の成長を牽引する主要な理由の1つであると特定しています。また、心血管疾患に関連する新たな病因ターゲットの同定や、世界の冠動脈性心疾患（CHD）の罹患率の高さが、市場の大きな需要につながるとしています。

地域別セグメンテーション
地域別比較
アジア：市場規模と予測 2024-2029
北米：市場規模と予測 2024-2029
欧州：市場規模と予測 2024-2029
世界のその他の地域：市場規模と予測 2024-2029
米国：市場規模と予測 2024-2029
中国：市場規模と予測 2024-2029
日本：市場規模と予測 2024-2029
インド：市場規模と予測 2024-2029
韓国：市場規模と予測 2024-2029
カナダ：市場規模と予測 2024-2029
英国：市場規模と予測 2024-2029
ドイツ：市場規模と予測 2024-2029
フランス：市場規模と予測 2024-2029
イタリア：市場規模と予測 2024-2029
市場機会：地域情勢別

第13章促進要因・課題・機会・抑制要因

市場促進要因
市場の課題
促進要因と課題の影響
市場の機会・抑制要因

第14章競合情勢

概要
競合情勢
混乱の状況
業界のリスク

第15章競合分析

企業プロファイル
企業ランキング指数
企業の市場ポジショニング
Abbott Laboratories
Astellas Pharma Inc.
AstraZeneca Plc
Aurobindo Pharma Ltd.
Bayer AG
Boehringer Ingelheim International GmbH
Bristol Myers Squibb Co.
Daiichi Sankyo Co. Ltd.
Dr Reddys Laboratories Ltd.
Eli Lilly and Co.
GlaxoSmithKline Plc
Johnson and Johnson Services Inc.
Merck and Co. Inc.
Pfizer Inc.
Viatris Inc.

第16章付録

図表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits6: Executive Summary - Chart on Market Segmentation by Type
Exhibits7: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ billion)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Cardiovascular Therapeutics Market 2019 - 2023 ($ billion)
Exhibits26: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
Exhibits27: Historic Market Size - Type Segment 2019 - 2023 ($ billion)
Exhibits28: Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ billion)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits39: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Distribution Channel
Exhibits41: Data Table on Comparison by Distribution Channel
Exhibits42: Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ billion)
Exhibits43: Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ billion)
Exhibits44: Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Retail Pharmacy - Market size and forecast 2024-2029 ($ billion)
Exhibits47: Data Table on Retail Pharmacy - Market size and forecast 2024-2029 ($ billion)
Exhibits48: Chart on Retail Pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Retail Pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits50: Chart on Online pharmacy - Market size and forecast 2024-2029 ($ billion)
Exhibits51: Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ billion)
Exhibits52: Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits53: Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
Exhibits54: Market opportunity by Distribution Channel ($ billion)
Exhibits55: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits56: Chart on Type - Market share 2024-2029 (%)
Exhibits57: Data Table on Type - Market share 2024-2029 (%)
Exhibits58: Chart on Comparison by Type
Exhibits59: Data Table on Comparison by Type
Exhibits60: Chart on Antithrombotic drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits61: Data Table on Antithrombotic drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits62: Chart on Antithrombotic drugs - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on Antithrombotic drugs - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Hypolipidemic drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits65: Data Table on Hypolipidemic drugs - Market size and forecast 2024-2029 ($ billion)
Exhibits66: Chart on Hypolipidemic drugs - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Hypolipidemic drugs - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits69: Data Table on Others - Market size and forecast 2024-2029 ($ billion)
Exhibits70: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits72: Market opportunity by Type ($ billion)
Exhibits73: Data Table on Market opportunity by Type ($ billion)
Exhibits74: Chart on Route of Administration - Market share 2024-2029 (%)
Exhibits75: Data Table on Route of Administration - Market share 2024-2029 (%)
Exhibits76: Chart on Comparison by Route of Administration
Exhibits77: Data Table on Comparison by Route of Administration
Exhibits78: Chart on Oral - Market size and forecast 2024-2029 ($ billion)
Exhibits79: Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
Exhibits80: Chart on Oral - Year-over-year growth 2024-2029 (%)
Exhibits81: Data Table on Oral - Year-over-year growth 2024-2029 (%)
Exhibits82: Chart on Injectable - Market size and forecast 2024-2029 ($ billion)
Exhibits83: Data Table on Injectable - Market size and forecast 2024-2029 ($ billion)
Exhibits84: Chart on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Injectable - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Transdermal - Market size and forecast 2024-2029 ($ billion)
Exhibits87: Data Table on Transdermal - Market size and forecast 2024-2029 ($ billion)
Exhibits88: Chart on Transdermal - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
Exhibits90: Market opportunity by Route of Administration ($ billion)
Exhibits91: Data Table on Market opportunity by Route of Administration ($ billion)
Exhibits92: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits93: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits94: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits95: Chart on Geographic comparison
Exhibits96: Data Table on Geographic comparison
Exhibits97: Chart on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits98: Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
Exhibits99: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits100: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ billion)
Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits110: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
Exhibits111: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on US - Market size and forecast 2024-2029 ($ billion)
Exhibits114: Data Table on US - Market size and forecast 2024-2029 ($ billion)
Exhibits115: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on China - Market size and forecast 2024-2029 ($ billion)
Exhibits118: Data Table on China - Market size and forecast 2024-2029 ($ billion)
Exhibits119: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits122: Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
Exhibits123: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on India - Market size and forecast 2024-2029 ($ billion)
Exhibits126: Data Table on India - Market size and forecast 2024-2029 ($ billion)
Exhibits127: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits130: Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
Exhibits131: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits134: Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
Exhibits135: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits138: Data Table on UK - Market size and forecast 2024-2029 ($ billion)
Exhibits139: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits142: Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
Exhibits143: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on France - Market size and forecast 2024-2029 ($ billion)
Exhibits146: Data Table on France - Market size and forecast 2024-2029 ($ billion)
Exhibits147: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits150: Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
Exhibits151: Chart on Italy - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on Italy - Year-over-year growth 2024-2029 (%)
Exhibits153: Market opportunity By Geographical Landscape ($ billion)
Exhibits154: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits155: Impact of drivers and challenges in 2024 and 2029
Exhibits156: Overview on criticality of inputs and factors of differentiation
Exhibits157: Overview on factors of disruption
Exhibits158: Impact of key risks on business
Exhibits159: Companies covered
Exhibits160: Company ranking index
Exhibits161: Matrix on companies position and classification
Exhibits162: Abbott Laboratories - Overview
Exhibits163: Abbott Laboratories - Business segments
Exhibits164: Abbott Laboratories - Key news
Exhibits165: Abbott Laboratories - Key offerings
Exhibits166: Abbott Laboratories - Segment focus
Exhibits167: SWOT
Exhibits168: Astellas Pharma Inc. - Overview
Exhibits169: Astellas Pharma Inc. - Product / Service
Exhibits170: Astellas Pharma Inc. - Key offerings
Exhibits171: SWOT
Exhibits172: AstraZeneca Plc - Overview
Exhibits173: AstraZeneca Plc - Product / Service
Exhibits174: AstraZeneca Plc - Key news
Exhibits175: AstraZeneca Plc - Key offerings
Exhibits176: SWOT
Exhibits177: Aurobindo Pharma Ltd. - Overview
Exhibits178: Aurobindo Pharma Ltd. - Product / Service
Exhibits179: Aurobindo Pharma Ltd. - Key offerings
Exhibits180: SWOT
Exhibits181: Bayer AG - Overview
Exhibits182: Bayer AG - Business segments
Exhibits183: Bayer AG - Key news
Exhibits184: Bayer AG - Key offerings
Exhibits185: Bayer AG - Segment focus
Exhibits186: SWOT
Exhibits187: Boehringer Ingelheim International GmbH - Overview
Exhibits188: Boehringer Ingelheim International GmbH - Product / Service
Exhibits189: Boehringer Ingelheim International GmbH - Key news
Exhibits190: Boehringer Ingelheim International GmbH - Key offerings
Exhibits191: SWOT
Exhibits192: Bristol Myers Squibb Co. - Overview
Exhibits193: Bristol Myers Squibb Co. - Product / Service
Exhibits194: Bristol Myers Squibb Co. - Key news
Exhibits195: Bristol Myers Squibb Co. - Key offerings
Exhibits196: SWOT
Exhibits197: Daiichi Sankyo Co. Ltd. - Overview
Exhibits198: Daiichi Sankyo Co. Ltd. - Product / Service
Exhibits199: Daiichi Sankyo Co. Ltd. - Key offerings
Exhibits200: SWOT
Exhibits201: Dr Reddys Laboratories Ltd. - Overview
Exhibits202: Dr Reddys Laboratories Ltd. - Business segments
Exhibits203: Dr Reddys Laboratories Ltd. - Key news
Exhibits204: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits205: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits206: SWOT
Exhibits207: Eli Lilly and Co. - Overview
Exhibits208: Eli Lilly and Co. - Product / Service
Exhibits209: Eli Lilly and Co. - Key offerings
Exhibits210: SWOT
Exhibits211: GlaxoSmithKline Plc - Overview
Exhibits212: GlaxoSmithKline Plc - Business segments
Exhibits213: GlaxoSmithKline Plc - Key news
Exhibits214: GlaxoSmithKline Plc - Key offerings
Exhibits215: GlaxoSmithKline Plc - Segment focus
Exhibits216: SWOT
Exhibits217: Johnson and Johnson Services Inc. - Overview
Exhibits218: Johnson and Johnson Services Inc. - Business segments
Exhibits219: Johnson and Johnson Services Inc. - Key news
Exhibits220: Johnson and Johnson Services Inc. - Key offerings
Exhibits221: Johnson and Johnson Services Inc. - Segment focus
Exhibits222: SWOT
Exhibits223: Merck and Co. Inc. - Overview
Exhibits224: Merck and Co. Inc. - Business segments
Exhibits225: Merck and Co. Inc. - Key news
Exhibits226: Merck and Co. Inc. - Key offerings
Exhibits227: Merck and Co. Inc. - Segment focus
Exhibits228: SWOT
Exhibits229: Pfizer Inc. - Overview
Exhibits230: Pfizer Inc. - Product / Service
Exhibits231: Pfizer Inc. - Key news
Exhibits232: Pfizer Inc. - Key offerings
Exhibits233: SWOT
Exhibits234: Viatris Inc. - Overview
Exhibits235: Viatris Inc. - Business segments
Exhibits236: Viatris Inc. - Key news
Exhibits237: Viatris Inc. - Key offerings
Exhibits238: Viatris Inc. - Segment focus
Exhibits239: SWOT
Exhibits240: Inclusions checklist
Exhibits241: Exclusions checklist
Exhibits242: Currency conversion rates for US$
Exhibits243: Research methodology
Exhibits244: Information sources
Exhibits245: Data validation
Exhibits246: Validation techniques employed for market sizing
Exhibits247: Data synthesis
Exhibits248: 360 degree market analysis
Exhibits249: List of abbreviations

Product Code: IRTNTR40101

The cardiovascular therapeutics market is forecasted to grow by USD 25.32 billion during 2024-2029, accelerating at a CAGR of 4.6% during the forecast period. The report on the cardiovascular therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing risk factors for cardiovascular diseases, availability of advanced diagnostic methods, and rising prevalence of hypercholesterolemia.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	4.3%
CAGR	4.6%
Incremental Value	$25.32 bn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's cardiovascular therapeutics market is segmented as below:

By Distribution Channel

Hospital pharmacy
Retail Pharmacy
Online pharmacy

By Type

Antithrombotic drugs
Hypolipidemic drugs
Others

By Route Of Administration

Oral
Injectable
Transdermal

By Geographical Landscape

Asia
North America
Europe
Rest of World (ROW)

This study identifies the advent of novel oral anticoagulants (NOACs) as one of the prime reasons driving the cardiovascular therapeutics market growth during the next few years. Also, identification of new pathogenic targets related to cardiovascular diseases and strong incidence of coronary heart disease (CHD) worldwide will lead to sizable demand in the market.

The report on the cardiovascular therapeutics market covers the following areas:

Cardiovascular Therapeutics Market sizing
Cardiovascular Therapeutics Market forecast
Cardiovascular Therapeutics Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading cardiovascular therapeutics market vendors that include Abbott Laboratories, Acutus Medical Inc., Amgen Inc., Astellas Pharma Inc., AstraZeneca PLC, Aurobindo Pharma Ltd., Bayer AG, Boehringer Ingelheim International GmbH, Bristol Myers Squibb Co., Daiichi Sankyo Co. Ltd., DR Reddys Laboratories Ltd., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline PLC, Johnson and Johnson Services Inc., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sun Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the cardiovascular therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Market Segmentation by Type
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ billion)
- Data Table on Global - Market size and forecast 2024-2029 ($ billion)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Cardiovascular Therapeutics Market 2019 - 2023
- Historic Market Size - Data Table on Global Cardiovascular Therapeutics Market 2019 - 2023 ($ billion)
5.2 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ billion)
5.3 Type segment analysis 2019 - 2023
- Historic Market Size - Type Segment 2019 - 2023 ($ billion)
5.4 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ billion)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ billion)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ billion)

6 Qualitative Analysis

6.1 The AI impact on Global Cardiovascular Therapeutics Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Distribution Channel

8.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
8.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
8.3 Hospital pharmacy - Market size and forecast 2024-2029
- Chart on Hospital pharmacy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hospital pharmacy - Market size and forecast 2024-2029 ($ billion)
- Chart on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Hospital pharmacy - Year-over-year growth 2024-2029 (%)
8.4 Retail Pharmacy - Market size and forecast 2024-2029
- Chart on Retail Pharmacy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Retail Pharmacy - Market size and forecast 2024-2029 ($ billion)
- Chart on Retail Pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Retail Pharmacy - Year-over-year growth 2024-2029 (%)
8.5 Online pharmacy - Market size and forecast 2024-2029
- Chart on Online pharmacy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Online pharmacy - Market size and forecast 2024-2029 ($ billion)
- Chart on Online pharmacy - Year-over-year growth 2024-2029 (%)
- Data Table on Online pharmacy - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ billion)
- Data Table on Market opportunity by Distribution Channel ($ billion)

9 Market Segmentation by Type

9.1 Market segments
- Chart on Type - Market share 2024-2029 (%)
- Data Table on Type - Market share 2024-2029 (%)
9.2 Comparison by Type
- Chart on Comparison by Type
- Data Table on Comparison by Type
9.3 Antithrombotic drugs - Market size and forecast 2024-2029
- Chart on Antithrombotic drugs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Antithrombotic drugs - Market size and forecast 2024-2029 ($ billion)
- Chart on Antithrombotic drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Antithrombotic drugs - Year-over-year growth 2024-2029 (%)
9.4 Hypolipidemic drugs - Market size and forecast 2024-2029
- Chart on Hypolipidemic drugs - Market size and forecast 2024-2029 ($ billion)
- Data Table on Hypolipidemic drugs - Market size and forecast 2024-2029 ($ billion)
- Chart on Hypolipidemic drugs - Year-over-year growth 2024-2029 (%)
- Data Table on Hypolipidemic drugs - Year-over-year growth 2024-2029 (%)
9.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ billion)
- Data Table on Others - Market size and forecast 2024-2029 ($ billion)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Type
- Market opportunity by Type ($ billion)
- Data Table on Market opportunity by Type ($ billion)

10 Market Segmentation by Route of Administration

10.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
10.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
10.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ billion)
- Data Table on Oral - Market size and forecast 2024-2029 ($ billion)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
10.4 Injectable - Market size and forecast 2024-2029
- Chart on Injectable - Market size and forecast 2024-2029 ($ billion)
- Data Table on Injectable - Market size and forecast 2024-2029 ($ billion)
- Chart on Injectable - Year-over-year growth 2024-2029 (%)
- Data Table on Injectable - Year-over-year growth 2024-2029 (%)
10.5 Transdermal - Market size and forecast 2024-2029
- Chart on Transdermal - Market size and forecast 2024-2029 ($ billion)
- Data Table on Transdermal - Market size and forecast 2024-2029 ($ billion)
- Chart on Transdermal - Year-over-year growth 2024-2029 (%)
- Data Table on Transdermal - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ billion)
- Data Table on Market opportunity by Route of Administration ($ billion)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ billion)
- Data Table on Asia - Market size and forecast 2024-2029 ($ billion)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.4 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ billion)
- Data Table on North America - Market size and forecast 2024-2029 ($ billion)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.5 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ billion)
- Data Table on Europe - Market size and forecast 2024-2029 ($ billion)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ billion)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ billion)
- Data Table on US - Market size and forecast 2024-2029 ($ billion)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ billion)
- Data Table on China - Market size and forecast 2024-2029 ($ billion)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ billion)
- Data Table on Japan - Market size and forecast 2024-2029 ($ billion)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.10 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ billion)
- Data Table on India - Market size and forecast 2024-2029 ($ billion)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.11 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ billion)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ billion)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ billion)
- Data Table on Canada - Market size and forecast 2024-2029 ($ billion)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ billion)
- Data Table on UK - Market size and forecast 2024-2029 ($ billion)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.14 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ billion)
- Data Table on Germany - Market size and forecast 2024-2029 ($ billion)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.15 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ billion)
- Data Table on France - Market size and forecast 2024-2029 ($ billion)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.16 Italy - Market size and forecast 2024-2029
- Chart on Italy - Market size and forecast 2024-2029 ($ billion)
- Data Table on Italy - Market size and forecast 2024-2029 ($ billion)
- Chart on Italy - Year-over-year growth 2024-2029 (%)
- Data Table on Italy - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ billion)
- Data Tables on Market opportunity By Geographical Landscape ($ billion)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Abbott Laboratories
- Abbott Laboratories - Overview
- Abbott Laboratories - Business segments
- Abbott Laboratories - Key news
- Abbott Laboratories - Key offerings
- Abbott Laboratories - Segment focus
- SWOT
15.5 Astellas Pharma Inc.
- Astellas Pharma Inc. - Overview
- Astellas Pharma Inc. - Product / Service
- Astellas Pharma Inc. - Key offerings
- SWOT
15.6 AstraZeneca Plc
- AstraZeneca Plc - Overview
- AstraZeneca Plc - Product / Service
- AstraZeneca Plc - Key news
- AstraZeneca Plc - Key offerings
- SWOT
15.7 Aurobindo Pharma Ltd.
- Aurobindo Pharma Ltd. - Overview
- Aurobindo Pharma Ltd. - Product / Service
- Aurobindo Pharma Ltd. - Key offerings
- SWOT
15.8 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
15.9 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.10 Bristol Myers Squibb Co.
- Bristol Myers Squibb Co. - Overview
- Bristol Myers Squibb Co. - Product / Service
- Bristol Myers Squibb Co. - Key news
- Bristol Myers Squibb Co. - Key offerings
- SWOT
15.11 Daiichi Sankyo Co. Ltd.
- Daiichi Sankyo Co. Ltd. - Overview
- Daiichi Sankyo Co. Ltd. - Product / Service
- Daiichi Sankyo Co. Ltd. - Key offerings
- SWOT
15.12 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
15.13 Eli Lilly and Co.
- Eli Lilly and Co. - Overview
- Eli Lilly and Co. - Product / Service
- Eli Lilly and Co. - Key offerings
- SWOT
15.14 GlaxoSmithKline Plc
- GlaxoSmithKline Plc - Overview
- GlaxoSmithKline Plc - Business segments
- GlaxoSmithKline Plc - Key news
- GlaxoSmithKline Plc - Key offerings
- GlaxoSmithKline Plc - Segment focus
- SWOT
15.15 Johnson and Johnson Services Inc.
- Johnson and Johnson Services Inc. - Overview
- Johnson and Johnson Services Inc. - Business segments
- Johnson and Johnson Services Inc. - Key news
- Johnson and Johnson Services Inc. - Key offerings
- Johnson and Johnson Services Inc. - Segment focus
- SWOT
15.16 Merck and Co. Inc.
- Merck and Co. Inc. - Overview
- Merck and Co. Inc. - Business segments
- Merck and Co. Inc. - Key news
- Merck and Co. Inc. - Key offerings
- Merck and Co. Inc. - Segment focus
- SWOT
15.17 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
- SWOT
15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

心血管治療薬の世界市場 2025-2029

Global Cardiovascular Therapeutics Market 2025-2029

目次

第1章エグゼクティブサマリー

第2章 Technavio分析

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：流通チャネル別

第9章市場セグメンテーション：タイプ別

第10章市場セグメンテーション：投与経路別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Distribution Channel

9 Market Segmentation by Type

10 Market Segmentation by Route of Administration

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

心血管治療薬の世界市場 2025-2029

Global Cardiovascular Therapeutics Market 2025-2029

目次

第1章 エグゼクティブサマリー

第2章 Technavio分析

第3章 市場情勢

第4章 市場規模

第5章 市場規模実績

第6章 定性分析

第7章 ファイブフォース分析

第8章 市場セグメンテーション：流通チャネル別

第9章 市場セグメンテーション：タイプ別

第10章 市場セグメンテーション：投与経路別

第11章 顧客情勢

第12章 地域別情勢

第13章 促進要因・課題・機会・抑制要因

第14章 競合情勢

第15章 競合分析

第16章 付録

Table of Contents

1 Executive Summary

2 Technavio Analysis

3 Market Landscape

4 Market Sizing

5 Historic Market Size

6 Qualitative Analysis

7 Five Forces Analysis

8 Market Segmentation by Distribution Channel

9 Market Segmentation by Type

10 Market Segmentation by Route of Administration

11 Customer Landscape

12 Geographic Landscape

13 Drivers, Challenges, and Opportunity/Restraints

14 Competitive Landscape

15 Competitive Analysis

16 Appendix

第1章エグゼクティブサマリー

第3章市場情勢

第4章市場規模

第5章市場規模実績

第6章定性分析

第7章ファイブフォース分析

第8章市場セグメンテーション：流通チャネル別

第9章市場セグメンテーション：タイプ別

第10章市場セグメンテーション：投与経路別

第11章顧客情勢

第12章地域別情勢

第13章促進要因・課題・機会・抑制要因

第14章競合情勢

第15章競合分析

第16章付録